Europe Liver Cancer Diagnostics Market Forecast to 2028 – COVID-19 Impact and Analysis – by Type (Laboratory Tests, Endoscopy, Imaging, Biopsy, and Others) and End User (Hospitals and Diagnostic Laboratories, Academic and Research Institutes, and CRO Laboratories)
The liver cancer diagnostics market in Europe is expected to grow from US$ 2,567.59 million in 2021 to US$ 4,308.57 million by 2028. It is estimated to grow at a CAGR of 7.7% from 2021 to 2028.
Hepatocellular carcinoma is the most frequent type of liver cancer. It starts in the major type of liver cell (hepatocyte) and is the most common type of primary liver cancer. Hepatocellular carcinoma occurs most often in people with chronic liver diseases, such as cirrhosis caused by hepatitis B or hepatitis C infection. Other kinds of liver cancer are significantly less prevalent, such as intrahepatic cholangiocarcinoma and hepatoblastoma. Cancer that begins in another area of the body, such as the colon, lung, or breast, and then spreads to the liver is called metastatic cancer.
Moreover, metastatic colon cancer is a kind of cancer that starts in the colon and spreads to the liver. For instance, In Europe, HCC accounts for around 47,000 deaths per year. The incidence is comparatively low except in Southern Europe, where the age-standardized incidence rate in men is 9.8 per 100,000 compared with 3.8 in Northern Europe, 4.6 in central and Eastern Europe, and 7.2 in Western Europe. However, in the UK, the HCC-based mortality rate is expected to rise by 14% between 2006 and 2025, representing the largest increase in male cancer.
Furthermore, being overweight or having obesity is a risk factor for liver cancer and non-alcoholic fatty liver disease is a common condition in obese people. People with a subtype of non-alcoholic fatty liver disease, known as non-alcoholic steatohepatitis (NASH), might develop cirrhosis, which can cause liver cancer. Certain inherited metabolic diseases can lead to cirrhosis. Lifestyle and behaviors, such as smoking cigarettes and drinking alcohol, are the leading cause of cirrhosis, which is linked with an increased risk of liver cancer.
Type 2 diabetes has been linked with an increased risk of liver cancer, usually in patients with other risk factors such as heavy alcohol use or chronic viral hepatitis. This risk may also be increased as people with type 2 diabetes tend to be overweight or obese, which, in turn, can cause liver problems. According to IDF Diabetes Atlas Tenth edition 2021, approximately 537 million adults (20-79 years) are living with diabetes at present. The total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045. The factors mentioned above are increasing the risk of liver cancer, thereby driving the liver cancer diagnostics market.
With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe Liver cancer diagnostics market at a substantial CAGR during the forecast period.
Europe Liver Cancer Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
Get more information on this report :
Europe Liver Cancer Diagnostics Market Segmentation
The Europe liver cancer diagnostics market is analyzed on the basis of type, end user, and country. Based on type, the market is segmented into laboratory tests, imaging, endoscopy, biopsy, and others. In 2021, the laboratory tests segment held the largest share of the market, and the imaging segment is expected to register a higher CAGR during the forecast period.
Based on laboratory tests, the market is segmented into blood tests and biomarkers. In 2021, the blood tests segment held a larger market share, and the same segment is expected to register the highest CAGR in the market during the forecast period.
Based on end user, the market is segmented into hospitals and diagnostic laboratories, academic and research institutes, and CRO laboratories. In 2021, the hospitals and diagnostic laboratories segment held the largest share of the market, and the same segment is expected to register a higher CAGR during the forecast period.
Based on country, the Europe liver cancer diagnostics market is segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe. In 2021, Germany held the largest market share, and the UK is expected to rise at the fastest CAGR during the forecast period.
Abbott; bioMerieux SA; F. HOFFMANN-LA ROCHE LTD.; Illumina, Inc.; Koninklijke Philips N.V.; QIAGEN; Siemens Healthineers AG; THERMO FISHER SCIENTIFIC INC.; GE Healthcare; and Perspectum are the leading companies in the Europe liver cancer diagnostics market.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Liver Cancer Diagnostics Market – By Type
1.3.2 Europe Liver Cancer Diagnostics Market – By End User
1.3.3 Europe Liver Cancer Diagnostics Market – By Country
2. Europe Liver Cancer Diagnostics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Liver Cancer Diagnostics Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Experts Opinion
5. Europe Liver Cancer Diagnostics Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Surging Prevalence of Liver Cancer
5.2 Market Restraints
5.2.1 Heavy Cost of Technologically Advanced Liver Cancer Diagnostic Solutions
5.3 Market Opportunities
5.3.1 Growing Demand for Point-of-Care Testing
5.4 Future Trends
5.4.1 Burgeoning Emergence of New Technologies
5.5 Impact Analysis
6. Europe Liver Cancer Diagnostics Market Analysis
6.1 Europe Liver Cancer Diagnostics Market Revenue Forecast and Analysis
7. Europe Liver Cancer Diagnostics Market Analysis – By Type
7.1 Overview
7.2 Europe Liver Cancer Diagnostics Market Revenue Share, by Type (2021 and 2028)
7.3 Laboratory Tests
7.3.1 Overview
7.3.2 Laboratory Tests: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.3.2.1 Blood Tests
7.3.2.1.1 Overview
7.3.2.1.2 Blood Tests: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.3.2.2 Biomarkers
7.3.2.2.1 Overview
7.3.2.2.2 Biomarkers: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Endoscopy
7.4.1 Overview
7.4.2 Endoscopy: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Imaging
7.5.1 Overview
7.5.2 Imaging: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Biopsy
7.6.1 Overview
7.6.2 Biopsy: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8. Europe Liver Cancer Diagnostics Market Analysis – By End User
8.1 Overview
8.2 Europe Liver Cancer Diagnostics Market Revenue Share, By End User (2021 and 2028)
8.3 Hospitals and Diagnostics Laboratories
8.3.1 Overview
8.3.2 Hospitals and Diagnostics Laboratories: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Academic and Research Institutes
8.4.1 Overview
8.4.2 Academic and Research Institutes: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.5 CRO Laboratories
8.5.1 Overview
8.5.2 CRO Laboratories: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9. Europe Liver Cancer Diagnostics Market – Country Analysis
9.1 Overview
9.1.1 Europe: Liver Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
9.1.1.1 Germany: Liver Cancer Diagnostics Market – Revenue and forecast to 2028 (USD Million)
9.1.1.1.1 Germany: Liver Cancer Diagnostics Market – Revenue and forecast to 2028 (USD Million)
9.1.1.1.2 Germany: Liver Cancer Diagnostics Market, by Type, 2019–2028 (USD Million)
9.1.1.1.2.1 Germany: Liver Cancer Diagnostics Market, by Laboratory Tests, 2019–2028 (USD Million)
9.1.1.1.3 Germany: Liver Cancer Diagnostics Market, by End User, 2019–2028 (USD Million)
9.1.1.2 UK: Liver Cancer Diagnostics Market – Revenue and forecast to 2028 (USD Million)
9.1.1.2.1 UK: Liver Cancer Diagnostics Market – Revenue and forecast to 2028 (USD Million)
9.1.1.2.2 UK: Liver Cancer Diagnostics Market, by Type, 2019–2028 (USD Million)
9.1.1.2.2.1 UK: Liver Cancer Diagnostics Market, by Laboratory Tests, 2019–2028 (USD Million)
9.1.1.2.3 UK: Liver Cancer Diagnostics Market, by End User, 2019–2028 (USD Million)
9.1.1.3 France: Liver Cancer Diagnostics Market – Revenue and forecast to 2028 (USD Million)
9.1.1.3.1 France: Liver Cancer Diagnostics Market – Revenue and forecast to 2028 (USD Million)
9.1.1.3.2 France: Liver Cancer Diagnostics Market, by Type, 2019–2028 (USD Million)
9.1.1.3.2.1 France: Liver Cancer Diagnostics Market, by Laboratory Tests, 2019–2028 (USD Million)
9.1.1.3.3 France: Liver Cancer Diagnostics Market, by End User, 2019–2028 (USD Million)
9.1.1.4 Spain: Liver Cancer Diagnostics Market – Revenue and forecast to 2028 (USD Million)
9.1.1.4.1 Spain: Liver Cancer Diagnostics Market – Revenue and forecast to 2028 (USD Million)
9.1.1.4.2 Spain: Liver Cancer Diagnostics Market, by Type, 2019–2028 (USD Million)
9.1.1.4.2.1 Spain: Liver Cancer Diagnostics Market, by Laboratory Tests, 2019–2028 (USD Million)
9.1.1.4.3 Spain: Liver Cancer Diagnostics Market, by End User, 2019–2028 (USD Million)
9.1.1.5 Italy: Liver Cancer Diagnostics Market – Revenue and forecast to 2028 (USD Million)
9.1.1.5.1 Italy: Liver Cancer Diagnostics Market – Revenue and forecast to 2028 (USD Million)
9.1.1.5.2 Italy: Liver Cancer Diagnostics Market, by Type, 2019–2028 (USD Million)
9.1.1.5.2.1 Italy: Liver Cancer Diagnostics Market, by Laboratory Tests, 2019–2028 (USD Million)
9.1.1.5.3 Italy: Liver Cancer Diagnostics Market, by End User, 2019–2028 (USD Million)
9.1.1.6 Rest of Europe: Liver Cancer Diagnostics Market – Revenue and forecast to 2028 (USD Million)
9.1.1.6.1 Rest of Europe: Liver Cancer Diagnostics Market – Revenue and forecast to 2028 (USD Million)
9.1.1.6.2 Rest of Europe: Liver Cancer Diagnostics Market, by Type, 2019–2028 (USD Million)
9.1.1.6.2.1 Rest of Europe: Liver Cancer Diagnostics Market, by Laboratory Tests, 2019–2028 (USD Million)
9.1.1.6.3 Rest of Europe: Liver Cancer Diagnostics Market, by End User, 2019–2028 (USD Million)
10. Europe Liver Cancer Diagnostics Market– Industry Landscape
10.1 Overview
10.2 Organic Developments
10.2.1 Overview
10.3 Inorganic Developments
10.3.1 Overview
11. Company Profiles
11.1 Abbott
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 bioMerieux SA
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 F. HOFFMANN-LA ROCHE LTD.
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Illumina, Inc.
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Koninklijke Philips N.V.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 QIAGEN
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Siemens Healthineers AG
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 THERMO FISHER SCIENTIFIC INC.
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 GE Healthcare
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 Perspectum
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Products and Services
11.10.4 Financial Overview
11.10.5 SWOT Analysis
11.10.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms
LIST OF TABLES
Table 1. Germany Liver Cancer Diagnostics Market, by Type– Revenue and forecast to 2028 (USD Million)
Table 2. Germany Liver Cancer Diagnostics Market, by Laboratory Tests– Revenue and forecast to 2028 (USD Million)
Table 3. Germany Liver Cancer Diagnostics Market, by End User – Revenue and forecast to 2028 (USD Million)
Table 4. UK Liver Cancer Diagnostics Market, by Type– Revenue and forecast to 2028 (USD Million)
Table 5. UK Liver Cancer Diagnostics Market, by Laboratory Tests– Revenue and forecast to 2028 (USD Million)
Table 6. UK Liver Cancer Diagnostics Market, by End User – Revenue and forecast to 2028 (USD Million)
Table 7. France Liver Cancer Diagnostics Market, by Type– Revenue and forecast to 2028 (USD Million)
Table 8. France Liver Cancer Diagnostics Market, by Laboratory Tests– Revenue and forecast to 2028 (USD Million)
Table 9. France Liver Cancer Diagnostics Market, by End User – Revenue and forecast to 2028 (USD Million)
Table 10. Spain Liver Cancer Diagnostics Market, by Type– Revenue and forecast to 2028 (USD Million)
Table 11. Spain Liver Cancer Diagnostics Market, by Laboratory Tests– Revenue and forecast to 2028 (USD Million)
Table 12. Spain Liver Cancer Diagnostics Market, by End User – Revenue and forecast to 2028 (USD Million)
Table 13. Italy Liver Cancer Diagnostics Market, by Type– Revenue and forecast to 2028 (USD Million)
Table 14. Italy Liver Cancer Diagnostics Market, by Laboratory Tests– Revenue and forecast to 2028 (USD Million)
Table 15. Italy Liver Cancer Diagnostics Market, by End User – Revenue and forecast to 2028 (USD Million)
Table 16. Rest of Europe: Liver Cancer Diagnostics Market, by Type– Revenue and forecast to 2028 (USD Million)
Table 17. Rest of Europe: Liver Cancer Diagnostics Market, by Laboratory Tests– Revenue and forecast to 2028 (USD Million)
Table 18. Rest of Europe Liver Cancer Diagnostics Market, by End User – Revenue and forecast to 2028 (USD Million)
Table 19. Organic Developments in the Liver Cancer Diagnostics Market
Table 20. Inorganic Developments in the Liver Cancer Diagnostics Market
Table 21. Glossary of Terms
LIST OF FIGURES
Figure 1. Europe Liver Cancer Diagnostics Market Segmentation
Figure 2. Europe Liver Cancer Diagnostics Market Segmentation, By Country
Figure 3. Europe Liver Cancer Diagnostics Market Overview
Figure 4. Laboratory Tests Segment Held Largest Share by Type in Europe Liver Cancer Diagnostics Market
Figure 5. The UK Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Europe Liver Cancer Diagnostics Market, Industry Landscape
Figure 7. Europe: PEST Analysis
Figure 8. Experts Opinion
Figure 9. Impact Analysis of Drivers and Restraint Pertaining to Europe Liver Cancer Diagnostics Market
Figure 10. Europe Liver Cancer Diagnostics Market – Revenue Forecast and Analysis – 2021- 2028
Figure 11. Europe Liver Cancer Diagnostics Market Revenue Share, by Type (2021 and 2028)
Figure 12. Laboratory Tests: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Blood Tests: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Biomarkers: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Endoscopy: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Imaging: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Biopsy: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Others: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Europe Liver Cancer Diagnostics Market Revenue Share, By End User (2021 and 2028)
Figure 20. Hospitals and Diagnostics Laboratories: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Academic and Research Institutes: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. CRO Laboratories: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Europe: Liver Cancer Diagnostics Market, by Key Country – Revenue (2021) (USD Million)
Figure 24. Europe: Liver Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 25. Germany: Liver Cancer Diagnostics Market – Revenue and forecast to 2028 (USD Million)
Figure 26. UK: Liver Cancer Diagnostics Market – Revenue and forecast to 2028 (USD Million)
Figure 27. France: Liver Cancer Diagnostics Market – Revenue and forecast to 2028 (USD Million)
Figure 28. Spain: Liver Cancer Diagnostics Market – Revenue and forecast to 2028 (USD Million)
Figure 29. Italy: Liver Cancer Diagnostics Market – Revenue and forecast to 2028 (USD Million)
Figure 30. Rest of Europe: Liver Cancer Diagnostics Market – Revenue and forecast to 2028 (USD Million)
- Abbott
- bioMerieux SA
- F. HOFFMANN-LA ROCHE LTD.
- Illumina, Inc.
- Koninklijke Philips N.V.
- QIAGEN
- Siemens Healthineers AG
- THERMO FISHER SCIENTIFIC INC.
- GE Healthcare
- Perspectum
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe liver cancer diagnostics market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Europe liver cancer diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the liver cancer diagnostics market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution